Case of the Month #48 Nephrogenic DI

Published 25/04/2024

References

  1. Diabetes Insipidus, Channing Hui; Myra Khan; Mohammed Z. Khan Suheb; Jared M. Radbel. June 1, 2023 

  1. Babey M, Kopp P, Robertson GL. Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol. 2011;7:701–714. 

  2. Kim GH, Lee JW, Oh YK, et al. Nephrogenic diabetes insipidus is associated with up-regulation of aquaporin-2, Na-Cl cotransporter and epithelieal sodium channel. J Am Soc Nephrol. 2004;15:2836–2843. 

  3. Lam SS, Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with non- steroidal anti-inflammatory drugs. Ren Fail. 1997;19: 183–188. 

  4. Makaryus AN, McFarlane SI. Diabetes insipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 2006; 73:65–71. 

  5. Ghirardello S, Malattia C, Scagnelli P, et al. Current perspective on the pathogenesis of central diabetes insipidus. J Pediatr Endocrinol Metab 2005; 18:631–645. 

  6. Robben JH, Kortenoeven ML, Sze M, et al. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci USA. 2009; 106(29):12195–12200. 

 

Familial forms of diabetes insipidus:   

8. clinical and molecular characteristics 

9. Muriel Babey, Peter Kopp and Gary L. Robertson